News / Events

Recent News View All News

Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

May 19, 2022

Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics

May 17, 2022

View All News

Upcoming Events View IR Calendar

Annual Meeting of Stockholders

Jun 14, 2022 • 10:00am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up